Logo image of V3V.DE

FAMICORD AG (V3V.DE) Stock Fundamental Analysis

Europe - FRA:V3V - DE000A0BL849 - Common Stock

5.3 EUR
-0.1 (-1.85%)
Last: 10/31/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, V3V scores 3 out of 10 in our fundamental rating. V3V was compared to 27 industry peers in the Health Care Providers & Services industry. V3V has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, V3V is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

V3V had positive earnings in the past year.
V3V had a positive operating cash flow in the past year.
In multiple years V3V reported negative net income over the last 5 years.
V3V had a positive operating cash flow in 4 of the past 5 years.
V3V.DE Yearly Net Income VS EBIT VS OCF VS FCFV3V.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10M -20M

1.2 Ratios

V3V has a Return On Assets of 1.61%. This is comparable to the rest of the industry: V3V outperforms 40.74% of its industry peers.
V3V has a Return On Equity of 10.63%. This is in the better half of the industry: V3V outperforms 62.96% of its industry peers.
Industry RankSector Rank
ROA 1.61%
ROE 10.63%
ROIC N/A
ROA(3y)-7.04%
ROA(5y)-3.48%
ROE(3y)-60.2%
ROE(5y)-34.49%
ROIC(3y)N/A
ROIC(5y)N/A
V3V.DE Yearly ROA, ROE, ROICV3V.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150

1.3 Margins

V3V has a Profit Margin of 3.20%. This is comparable to the rest of the industry: V3V outperforms 59.26% of its industry peers.
The Gross Margin of V3V (36.66%) is comparable to the rest of the industry.
V3V's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 3.2%
GM 36.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.67%
GM growth 5Y-8.9%
V3V.DE Yearly Profit, Operating, Gross MarginsV3V.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40

3

2. Health

2.1 Basic Checks

V3V does not have a ROIC to compare to the WACC, probably because it is not profitable.
V3V has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, V3V has more shares outstanding
The debt/assets ratio for V3V has been reduced compared to a year ago.
V3V.DE Yearly Shares OutstandingV3V.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
V3V.DE Yearly Total Debt VS Total AssetsV3V.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of 0.54, we must say that V3V is in the distress zone and has some risk of bankruptcy.
V3V has a worse Altman-Z score (0.54) than 85.19% of its industry peers.
The Debt to FCF ratio of V3V is 2.09, which is a good value as it means it would take V3V, 2.09 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.09, V3V belongs to the top of the industry, outperforming 96.30% of the companies in the same industry.
A Debt/Equity ratio of 0.56 indicates that V3V is somewhat dependend on debt financing.
V3V has a Debt to Equity ratio of 0.56. This is amongst the best in the industry. V3V outperforms 81.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 2.09
Altman-Z 0.54
ROIC/WACCN/A
WACC6.36%
V3V.DE Yearly LT Debt VS Equity VS FCFV3V.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 0.76 indicates that V3V may have some problems paying its short term obligations.
V3V has a Current ratio of 0.76. This is in the lower half of the industry: V3V underperforms 74.07% of its industry peers.
A Quick Ratio of 0.70 indicates that V3V may have some problems paying its short term obligations.
V3V's Quick ratio of 0.70 is in line compared to the rest of the industry. V3V outperforms 40.74% of its industry peers.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.7
V3V.DE Yearly Current Assets VS Current LiabilitesV3V.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

5

3. Growth

3.1 Past

V3V shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 109.51%, which is quite impressive.
V3V shows a small growth in Revenue. In the last year, the Revenue has grown by 7.73%.
V3V shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 30.44% yearly.
EPS 1Y (TTM)109.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%160%
Revenue 1Y (TTM)7.73%
Revenue growth 3Y57.65%
Revenue growth 5Y30.44%
Sales Q2Q%8.91%

3.2 Future

The Earnings Per Share is expected to grow by 30.68% on average over the next years. This is a very strong growth
Based on estimates for the next years, V3V will show a small growth in Revenue. The Revenue will grow by 2.88% on average per year.
EPS Next Y58.33%
EPS Next 2Y38.44%
EPS Next 3Y34.2%
EPS Next 5Y30.68%
Revenue Next Year9.33%
Revenue Next 2Y8.01%
Revenue Next 3Y7.82%
Revenue Next 5Y2.88%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
V3V.DE Yearly Revenue VS EstimatesV3V.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M 80M
V3V.DE Yearly EPS VS EstimatesV3V.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 37.86, which means the current valuation is very expensive for V3V.
70.37% of the companies in the same industry are cheaper than V3V, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.11. V3V is valued slightly more expensive when compared to this.
The Forward Price/Earnings Ratio is negative for V3V. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 37.86
Fwd PE N/A
V3V.DE Price Earnings VS Forward Price EarningsV3V.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300 -400 -500

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, V3V is valued a bit more expensive than 62.96% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, V3V is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 10.42
EV/EBITDA 11.12
V3V.DE Per share dataV3V.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as V3V's earnings are expected to grow with 34.20% in the coming years.
PEG (NY)0.65
PEG (5Y)N/A
EPS Next 2Y38.44%
EPS Next 3Y34.2%

0

5. Dividend

5.1 Amount

V3V does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

FAMICORD AG

FRA:V3V (10/31/2025, 7:00:00 PM)

5.3

-0.1 (-1.85%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-27 2025-08-27
Earnings (Next)11-21 2025-11-21
Inst Owners11.9%
Inst Owner ChangeN/A
Ins Owners58.45%
Ins Owner ChangeN/A
Market Cap93.49M
Revenue(TTM)80.64M
Net Income(TTM)2.58M
Analysts45.71
Price Target7.65 (44.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)15.38%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 37.86
Fwd PE N/A
P/S 1.16
P/FCF 10.42
P/OCF 7.72
P/B 3.85
P/tB N/A
EV/EBITDA 11.12
EPS(TTM)0.14
EY2.64%
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)0.51
FCFY9.6%
OCF(TTM)0.69
OCFY12.95%
SpS4.57
BVpS1.38
TBVpS-1.68
PEG (NY)0.65
PEG (5Y)N/A
Graham Number2.08
Profitability
Industry RankSector Rank
ROA 1.61%
ROE 10.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 3.2%
GM 36.66%
FCFM 11.13%
ROA(3y)-7.04%
ROA(5y)-3.48%
ROE(3y)-60.2%
ROE(5y)-34.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.67%
GM growth 5Y-8.9%
F-Score7
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 2.09
Debt/EBITDA 1.65
Cap/Depr 35.61%
Cap/Sales 3.89%
Interest Coverage N/A
Cash Conversion 147.25%
Profit Quality 347.6%
Current Ratio 0.76
Quick Ratio 0.7
Altman-Z 0.54
F-Score7
WACC6.36%
ROIC/WACCN/A
Cap/Depr(3y)60.39%
Cap/Depr(5y)47.49%
Cap/Sales(3y)7.53%
Cap/Sales(5y)6.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)109.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%160%
EPS Next Y58.33%
EPS Next 2Y38.44%
EPS Next 3Y34.2%
EPS Next 5Y30.68%
Revenue 1Y (TTM)7.73%
Revenue growth 3Y57.65%
Revenue growth 5Y30.44%
Sales Q2Q%8.91%
Revenue Next Year9.33%
Revenue Next 2Y8.01%
Revenue Next 3Y7.82%
Revenue Next 5Y2.88%
EBIT growth 1Y97.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year562.86%
EBIT Next 3Y110.83%
EBIT Next 5Y79.58%
FCF growth 1Y198.46%
FCF growth 3Y20.6%
FCF growth 5Y6%
OCF growth 1Y520.19%
OCF growth 3Y37.37%
OCF growth 5Y14.78%

FAMICORD AG / V3V.DE FAQ

What is the ChartMill fundamental rating of FAMICORD AG (V3V.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to V3V.DE.


What is the valuation status for V3V stock?

ChartMill assigns a valuation rating of 3 / 10 to FAMICORD AG (V3V.DE). This can be considered as Overvalued.


What is the profitability of V3V stock?

FAMICORD AG (V3V.DE) has a profitability rating of 3 / 10.


What is the financial health of FAMICORD AG (V3V.DE) stock?

The financial health rating of FAMICORD AG (V3V.DE) is 3 / 10.